Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2022-000398
Request Summary: The initial cover letters indicating the brand name of the reference drug product and the dosage form of the generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient levetiracetam. The Screening Acceptance Letters from Health Canada to the generic drug manufacturers confirming completion of screening of the Abbreviated New Drug Submissions (ANDS) for levetiracetam which appear in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22.
Disposition: Disclosed in part
Number of pages: 8